Advances in Nitrate Therapy
Advances in Nitrate Therapy
Nitrates have been for many years the cornerstone of cardiovascular therapy for various indications. Not only have nitrates stood the test of time for treatment of chronic stable angina pectoris, but the indications for them have markedly ex panded. They now include all forms of angina pectoris and myocardial ischemia, congestive heart failure and hypertensive emergencies. The beneficial effects of nitrates in all these conditions result from their vasodilatory properties, but it is still unclear whether the central or peripheral effects predominate in the thera peutic mechanism. Recently nitrates have been shown to fulfill the most important requirement for each and every drug - to reduce mortality. A large scale study revealed that isosorbide dinitrate, combined with hydralazine, reduced long-term mortality by 28% in patients with congestive heart failure. This finding will certainly stimulate research on nitrates, and it might be expected that interest in these drugs will markedly increase. The primarily used nitrates in clinical practice are nitroglycerin and the com plex organic nitrates, mainly isosorbide dinitrate. The organic mononitrates are now under clinical investigation, and isosorbide-5-mononitrate (IS-5-MN) appears to be especially promising.
2. The Mechanism of Action of Nitrates at the Cellular Level
B. Indications
3. Stable Angina Pectoris
4. The Mechanism of Action of Nitrates in Angina Pectoris
5. Nitrates Compared and Combined with Other Antianginal Drugs
6. Unstable Angina Pectoris
7. Long-Term Use of Nitrates in Angina Pectoris
8. Silent Ischemia
9. Acute Myocardial Infarction
10. Congestive Heart Failure
11. Congestive Heart Failure and Valvular Diseases
12. Long-Term Nitrate Therapy in Congestive Heart Failure
13. Nitrates Combined and Compared with Other Drugs in Congestive Heart Failure
14. Systemic Hypertension, Arrhythmias and Cardiac Surgery
15. Pulmonary, Abdominal, and Peripheral Vascular Effects
16. Non-Cardiovascular Indications for Nitrates
17. Nitrates in Children and the Elderly
C. Nitrate Formulations and Routes of Administration
18. Sublingual Tablets and Oral Spray
19. Intravenous Administration of Nitrates
20. Intracoronary Administration of Nitrates
21. Oral Administration of Nitrates
22. Mononitrates
23. Transdermal Administration of Nitrates
24. Buccal Nitroglycerin
D. Pharmacology
25. Clinical Pharmacology
26. Side Effects and Drug Interactions
27. Dosage and Administration
E. Conclusions
References.
A. Introduction and Mechanism
1. Introduction2. The Mechanism of Action of Nitrates at the Cellular Level
B. Indications
3. Stable Angina Pectoris
4. The Mechanism of Action of Nitrates in Angina Pectoris
5. Nitrates Compared and Combined with Other Antianginal Drugs
6. Unstable Angina Pectoris
7. Long-Term Use of Nitrates in Angina Pectoris
8. Silent Ischemia
9. Acute Myocardial Infarction
10. Congestive Heart Failure
11. Congestive Heart Failure and Valvular Diseases
12. Long-Term Nitrate Therapy in Congestive Heart Failure
13. Nitrates Combined and Compared with Other Drugs in Congestive Heart Failure
14. Systemic Hypertension, Arrhythmias and Cardiac Surgery
15. Pulmonary, Abdominal, and Peripheral Vascular Effects
16. Non-Cardiovascular Indications for Nitrates
17. Nitrates in Children and the Elderly
C. Nitrate Formulations and Routes of Administration
18. Sublingual Tablets and Oral Spray
19. Intravenous Administration of Nitrates
20. Intracoronary Administration of Nitrates
21. Oral Administration of Nitrates
22. Mononitrates
23. Transdermal Administration of Nitrates
24. Buccal Nitroglycerin
D. Pharmacology
25. Clinical Pharmacology
26. Side Effects and Drug Interactions
27. Dosage and Administration
E. Conclusions
References.
ISBN | 978-3-642-75836-2 |
---|---|
Artikelnummer | 9783642758362 |
Medientyp | Buch |
Auflage | 2. Aufl. |
Copyrightjahr | 2012 |
Verlag | Springer, Berlin |
Umfang | IV, 206 Seiten |
Abbildungen | IV, 206 p. |
Sprache | Englisch |